Qiagen
In Brief This Week: Qiagen, Oncocyte, Myriad Genetics, Mesa Biotech, and More
News items for the in vitro diagnostics industry for the week of May 31, 2021.
FDA Approves Amgen's Lumakras for NSCLC Alongside Companion Tests From Guardant Health, Qiagen
The approval makes Lumakras the first inhibitor of KRAS, once considered "undruggable," to reach the market for KRAS-mutated NSCLC.
Qiagen SARS-CoV-2 Serological Test Gets FDA Emergency Use Authorization
The test runs on a digital reader developed by Ellume and takes about 10 minutes to determine whether a person carries SARS-CoV-2 antibodies from a prior infection.
Qiagen Q1 Revenues Jump 52 Percent
The company beat analysts'Â estimates and exceeded previously provided guidance for revenue growth and EPS, driven by non-COVID-19-related product sales.
In Brief This Week: PerkinElmer, Qiagen, BioReference Laboratories, AstraZeneca, and More
News items for the in vitro diagnostics industry for the week of April 26, 2021.